Dynavax hepatitis B vaccine works; raises safety issues: FDA

(Reuters) - Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious cardiac events in patients given the vaccine than in those given a rival product, according to a preliminary Food and Drug Administration report published on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news